AEZS Aeterna Zentaris Inc

QUEBEC CITY, July 31 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (NASDAQ:AEZSNASDAQ:TSX:NASDAQ:AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its Senior Vice President and Chief Medical Officer, Paul Blake, M.D., will present a company overview at the upcoming BMO Capital Markets 2008 Focus on Healthcare Conference on Tuesday, August 5, 2008 at 1:45 pm (eastern time), in Room 3 of the Millennium Broadway Hotel in New York City. Furthermore, Professor, Jurgen Engel, Ph.D., Executive Vice President and Chief Scientific Officer at AEterna Zentaris will also present a company overview at the 28th Annual Canaccord Adams Global Growth Conference on Wednesday, August 13, 2008 at 10:00 am (Eastern Time) in the London room of the Intercontinental Hotel in Boston. A live webcast of Professor Engel's presentation will be available on AEterna Zentaris' website at http://www.aezsinc.com/ in the Investors section. A replay will also be available for a period of 30 days on the Company's website. About AEterna Zentaris Inc. AEterna Zentaris Inc. is global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aezsinc.com/. DATASOURCE: AETERNA ZENTARIS INC. CONTACT: Investor relations: Dennis Turpin, CA, Senior Vice President and Chief Financial Officer, (908) 626-5503, ; Media relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext. 406,

Copyright